Posts

Showing posts with the label Pharma Industry

Understanding Consumer Packaged Good (CPG) Market Dynamics – Asrar Qureshi’s Blog Post 1157

Image
Understanding Consumer Packaged Good (CPG) Market Dynamics – Asrar Qureshi’s Blog Post #1157 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1157 for Pharma Veterans. Pharma    Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Kari Alfonso Credit: junjie xu Credit: Polina Tankilevich Credit: Rachel Claire Preamble Consumer Packaged Goods, or CPG, are the everyday items we buy, use, and toss. They’re all around us: the food, toiletries, snacks, and drinks that fill our pantries and bathrooms. But behind these familiar products lies a dynamic, $3.18 trillion global industry (2024 estimate), one that is adapting rapidly to sustainability demands, digital habits, and shifting consumer expectations. Here’s what you need to know about CPG: how it’s defined, how it’s evolving, and why it matters. More pharmaceutical companies have added ...

Balancing Execution and Innovation in a Fast-Changing World – Asrar Qureshi’s Blog Post 1156

Image
Balancing Execution and Innovation in a Fast-Changing World – Asrar Qureshi’s Blog Post 1156 Dear Colleagues! This is Asrar Qureshi’s Blog Post 1156 for Pharma Veterans. Pharma    Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: cottonbro studio Credit: Karolina Grabowska Preamble This blog post speaks particularly to senior managers who strategize, execute, and are responsible for results today and tomorrow. In today’s dynamic environment, organizations are caught between two equally critical imperatives: executing the existing strategy with discipline and efficiency and simultaneously doing constant innovation to remain relevant in a world of disruption. Lean too much into execution, and the company risks becoming stagnant, missing the next wave of change. Lean too heavily into innovation, and execution suffers, creating instabilit...

Leader for Everyone – Asrar Qureshi’s Blog Post #1155

Image
Leader for Everyone – Asrar Qureshi’s Blog Post #1155 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1155 for Pharma Veterans. Pharma    Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: August de Richelieu Credit: JLT Project Credit: RDNE Stock Project Preamble “We don’t get to choose who we lead. We have to lead everybody. We have to get them from where we are to where we’re trying to go as a team.” Robert E. Siegel. Author of ‘The Systems Leader – Mastering the Cross Pressures that Make or Break Today’s Companies’.  Leadership, at its core, is not about comfort, convenience, or selective engagement. It is about responsibility. The quote above encapsulates one of the most profound truths of leadership: you don’t get to pick and choose your followers the way you might select friends, colleagues, or even employees. Once you ...

Pickings by Pharma Veterans Fortnightly Newsletter #30 – August 31, 2025

Image
Pickings by Pharma Veterans Fortnightly Newsletter #30 – August 31, 2025 This newsletter is the offering from Asrar Qureshi, Founder of Pharma Veterans. It will bring to you a selection of Pharma Industry news and developments from Pakistan, region, and the world. It will be published fortnightly on alternate Sundays. For queries and sending information, please send email to pharmaveterans2017@gmail.com. SPECIAL NOTE The objective of this newsletter is to share important news from the US and Europe, where exciting new research and development in drugs is going on. News from India, Bangladesh, and Pakistan are included to show where Pakistan stands vis-à-vis the region. This is done in order that Pharma Industry in Pakistan may take necessary actions for course setting and long-term strategy making. PAKISTAN • Patients in Pakistan will soon have access to safer and higher-quality medicines as the Drug Regulatory Authority of Pakistan (DRAP) has adopted international pharmaceutical sta...

Navigating Uncertainty – Asrar Qureshi’s Blog Post 1151

Image
Navigating Uncertainty – Asrar Qureshi’s Blog Post 1151 Dear Colleagues! This is Asrar Qureshi’s Blog Post 1151 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: energepic Credit: Fox Credit: Andrea Piacquadio Preamble This blog post takes insights from a recent McKinsey article. Link at the end. In today’s rapidly shifting world, disruption is no longer a rare event; it is the norm. A recent McKinsey study revealed that 84% of business leaders feel underprepared for future disruptions, with geopolitical shifts standing out as a key concern. Geopolitical changes affect all organizations in all countries, not just global companies in developed countries. For example, a Pakistani company doing business only in Pakistan is not immune to global changes as it affects supply chains, exchange rates, local currency value, pr...

Technical Expertise vs Customer Experience – Asrar Qureshi’s Blog Post 1150

Image
Technical Expertise vs Customer Experience – Asrar Qureshi’s Blog Post 1150 Dear Colleagues! This is Asrar Qureshi’s Blog Post 1150 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Anna Shvets Credit: Pixabay Preamble I am a regular reader of a technology newsletter by Rob Howard at innovatingwithai.com.  A recent edition talked about the disaster created by OpenAI upon itself when they launched GPT5.0 and disconnected earlier versions. The consumers were confused and unhappy. The analysis is that being a technology company is one part, while being a consumer company is an altogether different area, where OpenAI did not exist. Similar situations are seen in Pharma industry when a high-tech, great product does not take into account user/consumer/patient experience. Some examples follow. Technology vs Commerciali...

Pharma Marketing by 2030 – Asrar Qureshi’s Blog Post #1148

Image
Pharma Marketing by 2030 – Asrar Qureshi’s Blog Post #1148 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1148 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Timur Saglambilek Credit: Mikael Blomkvist Preamble I discussed how pharmaceutical selling is likely to change during the next five years. Now, this is a broad vision of how pharmaceutical marketing may look like by 2030, with a special lens on Pakistan. It is more complex than selling because marketing is the brain and it works for present and future simultaneously. What will change materially by 2030 Omnichannel becomes the default, not “digital vs. rep,” but both. HCPs increasingly want integrated experiences across rep visits, virtual touchpoints, portals, webinars, medical content hubs, and peer channels. Medical and commercial touchpoints will be o...

Pickings by Pharma Veterans Newsletter #29 – August 17, 2025

Image
Pickings by Pharma Veterans Newsletter #29 – August 17, 2025 This newsletter is the offering from Asrar Qureshi, Founder of Pharma Veterans. It will bring to you a selection of Pharma Industry news and developments from Pakistan, region, and the world. It will be published fortnightly on alternate Sundays. For queries and sending information, please send email to pharmaveterans2017@gmail.com. SPECIAL NOTE The objective of this newsletter is to share important news from the US and Europe, where exciting new research and development in drugs is going on. News from India, Bangladesh, and Pakistan are included to show where Pakistan stands vis-à-vis the region. This is done in order that Pharma Industry in Pakistan may take necessary actions for course setting and long-term strategy making. PAKISTAN • Highnoon Laboratories Limited has entered into a strategic partnership with Beximco Pharmaceuticals Limited, a leading pharmaceutical manufacturer based in Bangladesh. This alliance marks a...

Employee Engagement – Latest from Gallup – Asrar Qureshi’s Blog Post #1144

Image
Employee Engagement – Latest from Gallup – Asrar Qureshi’s Blog Post #1144 Dear Colleagues! This is Asrar Qureshi’s Blog Post 1144 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Felicity Tai Credit: Kindel Media Credit: Thirdman Preamble This blog post is inspired by the Gallup article “Anemic Employee Engagement Points to Leadership Challenges”, published on August 6, 2025. (Link at the end). This piece explores the growing challenges of workplace engagement, offers insight into leadership’s role, and provides actionable strategies leaders can adopt today. Anemic Employee Engagement: A Wake-Up Call for Leadership When employees stop caring, organizations slip. Gallup’s recent findings, what they call “anemic employee engagement” aren’t just statistics; they are a red flag signaling that traditional leadership app...